World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 22 February 2013
Main ID:  ACTRN12611000702910
Date of registration: 08/07/2011
Primary sponsor: Individual Dr Michael Valenzuela
Public title: Cognitive and neural benefits of brain training.
Scientific title: Double-blind, randomised clinical trial timecourse changes in response to computerised cognitive training compared to active control training in a group of cognitively healthy older adults, as measured with a battery of cognitive tests and MRI scans.
Date of first enrolment: 28/06/2011
Target sample size: 80
Recruitment status: Closed: follow-up continuing
URL:  http://www.anzctr.org.au/ACTRN12611000702910.aspx
Study type:  Interventional
Study design:  Randomised controlled trial  Parallel
Countries of recruitment
Australia
Contacts
Name:   Mr Mr Amit Lampit
Address:  Regenerative Neuroscience Group Brain and Mind Research Institute University of Sydney 100 Mallet St Camperdown NSW 2050, Australia
Telephone: +61 9114 4134
Email: amit.lampit@sydney.edu.au
Affiliation: 
Name:   A/Prof Dr Michael Valenzuela
Address:  Regenerative Neuroscience Group Brain and Mind Research Institute University of Sydney 100 Mallet St Camperdown NSW 2050, Australia
Telephone: +61 2 9114 4135
Email: michael.valenzuela@sydney.edu.au
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: (1) Non-demented, non-depressed older adults; (2) physical ability to attend brain training sessions 3 times a week
Exclusion criteria: (1) history, diagnosis or treatment for dementia (of any aetiology); (2) diagnosis or treatment for depression in last 6 months; (3) history of stroke in last 12 months; (4) major neurological disorder requiring current treatment (epilepsy); (5) major psychiatric disorder requiring current treatment (schizophrenia, bipolar disorder); (6) physical (sensory or motor) impairment that would limit ability to engage with training; (7) lack of personal informant who sees the person at least once a week; (8) current undertaking of any other Brain Training program; (9) current alcohol abuse.

Age minimum: 65 Years
Age maximum: 0 No limit
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Neuroplasticity in the cognitively healthy elderly
Intervention(s)
26 exercises from the COGPACK package, a suite of exercises that are largely based upon well-established neuropsychological tests and principles. Multiple exercises will be used to target the one generic cognitive domain and exercises will include both verbal and visual modalities. Training will be administered in three 1-hour sessions every week for a total period of 12 weeks (i.e. a total of 36 hours), supervised by a member of the research team.
Primary Outcome(s)
Scores in (1) A subset of tests taken from Mindstreams: Verbal Memory, Non Verbal Memory, Staged Information Processing Speed, Stroop Interference; (2) "Stockings of Cambridge," a problem solving test from the CANTAB.
Scores in (1)a computer-based adaptation of WAIS 4 Matrix Reasoning test; (2) Controlled Oral Word Association Test (COWAT); (3) the Boston Naming Test (short versions) and (4) a computerised adaptation of the Recognition Memory Test.
Secondary Outcome(s)
(1) Structural plasticity: T1-weighted isometric 3D scan; (2) Biochemical plasticity: Magnetic resonance spectroscopic analysis of metabolites in both the hippocampus and posterior cingulate; (3) Functional plasticity: resting state fMRI scan; and (4) White matter plasticity: Diffusion Tractography Imaging. These outcomes collected on a subsample of n=15 subjects.
Bayer Instrumental Activities of Daily Living (B-ADL)
Secondary ID(s)
Nil
Source(s) of Monetary Support
Primary Dementia Collaborative Research Centre
Secondary Sponsor(s)
A/Prof Sharon Naismith
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history